General Psychiatry and Psychology (Adult)
Showing 351-400 of 419 Results
-
David Smith, M.D.
Academic Staff - Hourly - CSL, Psychiatry and Behavioral Sciences
BioDr. Smith is a psychiatrist and clinical psychopharmacologist in private practice in Palo Alto, CA, and an Adjunct Professor in the Department of Psychiatry & Behavioral Sciences at Stanford University School of Medicine. He majored in both biological science and English literature at Cornell University, received his M.D. from UCLA, and completed his psychiatry residency and NIMH research fellowship at Stanford University School of Medicine and Hospital.
Dr. Smith is currently co-director of the pre-clerkship curriculum in psychiatry at the Stanford medical school. -
Ethan Solomon
Instructor, Psychiatry and Behavioral Sciences
BioDr. Solomon is an Instructor in the Department and Psychiatry and Behavioral Sciences and a member of the Stanford Precision Neurotherapeutics Lab. He earned his MD and PhD in Bioengineering through the Medical Scientist Training Program at the University of Pennsylvania, and completed residency training in psychiatry at the Stanford School of Medicine. His research focuses on electrophysiological techniques (stereo-EEG/ECoG, scalp EEG) and brain stimulation technologies (direct electrical stimulation, deep brain stimulation, and transcranial magnetic stimulation) to understand cognitive and perceptual processes in psychiatric illness. Dr. Solomon is a recipient of an NIMH K99 grant to study the use of theta burst stimulation in hippocampal-cortical networks of patients with schizophrenia.
-
Natalie Solomon
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioDr. Solomon is a licensed psychologist, board certified in behavioral sleep medicine, and a clinical associate professor in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. Dr. Solomon conducts research as a member of the Computational Psychiatry, Neuroimaging, Sleep Lab (CoPsyN Sleep Lab) and treats patients in the Sleep Health and Insomnia Program (SHIP). Dr. Solomon specializes in the study and treatment of sleep disorders. Her clinical interests include the intersection of sleep difficulties with overall quality of life and women’s health. Dr. Solomon enjoys treating a variety of sleep difficulties, including insomnia, hypnotic dependence, circadian rhythm disturbances, NREM parasomnias, and nightmares. Dr. Solomon additionally consults, teaches undergrads, graduate students, and continuing studies, supervises postdoctoral fellows, and trains providers to deliver insomnia treatment.
-
Barbara Sommer
Associate Professor of Psychiatry and Behavioral Sciences at the Stanford University Medical Center, Emerita
Current Research and Scholarly InterestsI am interested in the clinical investigation of cognitive stresses during younger adulthood that may give rise to frank intellectual impairment with older age. Examples may include specific kinds of chronically taken medications.
-
Maria-Christina Stewart
Adjunct Clinical Instructor, Psychiatry and Behavioral Sciences
BioDr. Stewart specializes in the prevention and treatment of eating, obsessive-compulsive, anxiety, and depressive disorders - and the intersection between them. At Stanford she lectures on evidence-based eating disorder treatments for children and adolescents. Dr. Stewart also runs a private practice, writes, consults, lectures, and hosts the 'Meaning Vs Merit' podcast - exploring how to find meaning in our achievement and merit-focused culture.
-
Nicole Stigler
Life Science Research Professional 1, Psych/General Psychiatry and Psychology (Adult)
BioI am driven to understand the neural mechanisms underlying psychiatric disorders to improve mental health outcomes.
-
Steven Tate
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Steven Tate serves as a Clinical Assistant Professor specializing in addiction medicine within the Department of Psychiatry & Behavioral Sciences at Stanford University School of Medicine. He earned his medical degree from the University of Chicago and his master's in medical statistics from the London School of Hygiene and Tropical Medicine. He then completed his internal medicine residency at the University of Pennsylvania and his fellowship in addiction medicine at Stanford. Dr. Tate sees patients in the Stanford Addiction Medicine/Dual Diagnosis Clinic and in the hospital on the Inpatient Addiction Medicine Consult Service. He is interested in teaching evidence-based addiction medicine and translating evidence into practice to improve the care of patients with substance use disorders.
-
Allison L. Thompson, Ph.D.
Clinical Professor, Psychiatry and Behavioral Sciences
BioDr. Allison Thompson specializes in the treatment of Post-Traumatic Stress Disorder, anxiety and depression, and severe mental illness. She has practiced at Stanford since 2008. She has a special interest in the treatment of underrepresented and underserved populations, such as people of color.
-
Lénie Torregrossa, PhD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Lénie Torregrossa is a clinical psychologist and Clinical Assistant Professor in the Department of Psychiatry and Behavioral Sciences at the Stanford University School of Medicine. At Stanford, she works on the inpatient psychiatric units and in the INSPIRE clinic.
Dr. Torregrossa specializes in schizophrenia spectrum disorders, psychosis, and serious mental illness. Her approach to treatment is person-centered and recovery-focused, grounded in cognitive behavioral therapy (CBT) and informed by acceptance and commitment therapy (ACT). She is a CBT for Psychosis (CBTp) trainer and a member of the early psychosis coordinated specialty care team (INSPIRE360) at INSPIRE. Dr. Torregrossa's research focuses on risk and protective factors for schizophrenia spectrum disorders, self-disturbances in schizophrenia, and improving treatments for psychosis. She serves on the steering committee of the North America CBT for Psychosis Network (NACBTpN) and is a member of the Schizophrenia International Research Society, the Society of Biological Psychiatry, and the American Psychological Association. -
Jacob Towery
Adjunct Clinical Instructor, Psychiatry and Behavioral Sciences
BioJacob Towery, MD is an adolescent and adult psychiatrist in private practice in Palo Alto, California. He attended Duke University for his undergraduate studies, University of Virginia for medical school, and Stanford for his residency in adult psychiatry and fellowship in adolescent psychiatry. He is the author of "The Anti-Depressant Book," available on Amazon. He currently serves on the Adjunct Faculty at Stanford University School of Medicine. He enjoys seeing patients, snowboarding, scuba diving, traveling, reading fantasy novels, meditating, spending quality time with other humans, making gratuitously long lists, and writing about himself in the third person. More information can be found at www.jacobtowerymd.com
-
Jahnia Gabrielle Treadwell
Casual - Non-Exempt, Psych/General Psychiatry and Psychology (Adult)
BioJahnia Treadwell is a Clinical Psychology doctoral student at the PAU-Stanford PsyD Consortium, graduating in 2030. Originally from Allentown, PA, and now in San Jose, CA, she holds a BA in Psychology from Bucknell University.
As an undergraduate, Jahnia completed an 80-hour certification at Transitions of PA to become an advocate counselor for the domestic violence crisis shelter. Her work in the Safe House and Housing Department strengthened her dedication to trauma-informed care and serving vulnerable populations.
Her clinical interests include trauma-informed therapy for at-risk youth and adults, emphasizing culturally responsive and spiritually integrated care. She plans to launch a private practice LLC offering Christian therapy and holistic wellness. Her long-term vision includes a multidisciplinary healing space with massage and acupuncture, an Autonomous Sensory Meridian Response (ASMR) clinic, and a soul cycling studio—uniting mental health, physical restoration, and spiritual renewal. -
Mickey Trockel
Professor of Psychiatry and Behavioral Sciences
BioMickey Trockel is the Director of Evidence Based Innovation for the Stanford University School of Medicine WellMD Center. His development of novel measurement tools has led to growing focus on professional fulfillment as a foundational aim of efforts to promote physician well-being. His scholarship also identifies interpersonal interactions at work as a modifiable core determinate of an organizational culture that cultivates wellness.
Dr. Trockel serves as the chair of the Physician Wellness Academic Consortium Scientific Board, which is a group of academic medical centers working together to improve physician wellbeing. The consortium sites have adopted the physician wellness assessment system Dr. Trockel and his colleagues have developed, which offers longitudinal data for benchmarking and natural experiment based program evaluation. His previous research included focus on college student health, and evaluation of the efficacy of a national evidence based psychotherapy dissemination effort. His more recent scholarship has focused on physician wellbeing. He is particularly interested in developing and demonstrating the efficacy of interventions designed to promote wellbeing by improving social culture determinants of wellbeing across student groups, employee work teams, or larger organizations. -
Yuri Tsutsumi
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsClinical Psychology
-
Jason Tucciarone, MD, PhD
Assistant Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology)
BioJason Tucciarone, MD, PhD is an Assistant Professor in the Department of Psychiatry and Behavioral Sciences at Stanford School of Medicine. A neuroscientist and psychiatrist, he leads a laboratory focused on uncovering the biological mechanisms of mental illness and developing novel therapies for mood disorders and addiction. His research centers on defining new cell types and evolutionarily conserved neural circuits involved in emotional processing, with the goal of identifying new therapeutic entry points. Using optogenetic, chemogenetic, neuroimaging, and behavioral approaches in mouse models of addiction, his lab investigates vulnerable brain circuitry underlying opioid use disorder. He also works and collaborates with the Depression Research Clinic, participating in academic and industry sponsored clinical trials investigating novel antidepressant therapies.
Clinically, Dr. Tucciarone works in Stanford’s Neuropsychiatry Clinic, where he treats patients with complex presentations at the interface of psychiatry and neurology, with particular interest in functional neurological disorders. He also sees a small cohort of psychotherapy patients in the Individual Psychotherapy Clinic and works shifts on Stanford’s inpatient psychiatry units.
Dr. Tucciarone completed his psychiatry training through Stanford’s Research Residency Track, where he conducted postdoctoral research under the supervision of Drs. Robert Malenka and Alan Schatzberg. During residency, his research examined neural circuits recruited during opioid withdrawal and explored strategies to enhance the anti-suicidal effects of ketamine through μ-opioid receptor partial agonism.
He received his bachelor’s degree in biology and philosophy from Union College, followed by three years as a Post-Baccalaureate IRTA fellow at the National Institute of Neurological Disorders and Stroke, where he developed MRI-reportable contrast agents to map neuronal connectivity. He then entered the Medical Scientist Training Program (MD/PhD) at Stony Brook University, completing his PhD in neuroscience under the mentorship of Dr. Josh Huang at Cold Spring Harbor Laboratory. His doctoral work used mouse genetic approaches to dissect excitatory and inhibitory cortical circuits, with a focus on chandelier interneurons in the prefrontal cortex.
In addition to his research and clinical work, Dr. Tucciarone is deeply committed to teaching and mentorship. During residency, he helped restructure neuroscience education for trainees and currently teaches introductory lectures on the neuroscience of addiction, PTSD, psychosis, and mood disorders. He leads resident group supervision in introductory psychodynamic psychotherapy and supervises undergraduates, medical students, residents, and clinical fellows in psychiatry clinics. -
Dona Tversky
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDona A. Tversky, MD, MPH is a psychiatrist and clinical educator whose work focuses on the intersection of psychodynamic psychotherapy and community-based preventive mental health. Her mission centers on the creation of psychologically healthy environments—at both the individual and systemic levels—to foster resilience and expand the scope of preventive psychiatric care. At Stanford, Dr. Tversky focuses on the training of future clinicians and the dissemination of psychiatric literacy. She serves as a clinical supervisor for residents in psychodynamic psychotherapy and teaches "How to Think Like a Shrink" for both Stanford undergraduates and the Stanford Continuing Studies program.
In her community-based work, Dr. Tversky serves as an educator and psychiatric consultant for the integrated behavioral health team at Ravenswood Family Health Center in East Palo Alto. Her current initiatives bridge clinical care with environmental design to promote wellness; these include a collaborative project to connect the Ravenswood clinic to the Baylands Bay Trail and a partnership with the Stanford d.school, Peninsula Healthcare Connection, and Palo Alto Medical Foundation to develop a psychology-informed clinic for unhoused individuals near the Stanford campus. -
Mirko Uljarevic
Clinical Associate Professor, Psychiatry and Behavioral Sciences
Affiliate, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child DevelopmentBioI am a medically trained researcher focused academic with a background in developmental psychopathology, psychometrics and big data science. My research takes a life-span perspective and is driven by the urgent need to improve outcomes for people with autism and other neuropsychiatric (NPD) disorders and neurodevelopmental conditions (NDD). My primary research interest has focused on combining cutting-edge psychometric procedures and a big data approach to better understand structure of clinical phenotypes across autism and other NPD and NDD and on using this knowledge to improve existing and develop new clinical assessments that are more effective for screening and diagnosis, tracking the natural and treatment-related symptom progression and for use in genetic and neurobiological studies. In addition to my focus on the development of outcome measures, I have collaborated with leading psychopathology researchers and groups in the United States, Europe and Australia on numerous projects spanning a range of topics including genetics, treatment and employment, with a particular focus on understanding risk and resilience factors underpinning poor mental health outcomes in adolescents and adults. Most recently, through several competitively funded projects, I have led the statistical analyses to uncover the latent structure of social and communication and restricted and repetitive behaviors (RRB) clinical phenotypes across NPD and NDD. These findings have enabled us to (i) start capturing and characterizing a highly variable social functioning phenotype across a range of disorders and understanding mechanisms underpinning this variability, (ii) combine phenotypic and genetic units of analyses to advance our understanding of the genetic architecture of RRB, and (iii) focus on identification and characterization of subgroups of individuals that share distinct symptom profiles and demonstrate clinical utility and neurobiological validity. Importantly, this work has provided key information for developing a programmatic line of research aimed at developing novel, comprehensive assessment protocols that combine parent and clinician reports, objective functioning indicators and incorporate state-of-the-art psychometric, mobile and connected technologies and procedures.
I am a co-director of the recently established Program for Psychometrics and Measurement-Based Care (https://med.stanford.edu/sppmc.html) that aims to bring together world-leading expertise in clinical science, psychometrics, and big data analytics to bridge the gap between the science of measurement development and clinical practice and bring improvements to both clinical care and research. -
Keara E. Valentine
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioKeara E. Valentine, Psy.D., is a clinical assistant professor at Stanford University School of Medicine in the Psychosocial Treatment Clinic and OCD Clinic, where she specializes in the assessment and treatment of OCD and related disorders. Dr. Valentine utilizes behavioral-based therapies including Cognitive Behavioral Therapy (CBT) and Exposure and Response Prevention (ERP) with children, adolescents, and adults experiencing anxiety-related disorders.
Dr. Valentine completed an APA accredited pre-doctoral internship at Alexian Brothers Behavioral Health Hospital, where she complete a rotation in OCD and anxiety disorders and a rotation in Eating Disorders. Dr. Valentine has experience working with individuals with OCD, anxiety, and/or eating disorders at various levels of care including outpatient, partial hospitalization, residential, and inpatient. -
Axel Valle, PsyD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Axel Valle is a licensed clinical psychologist providing individual psychotherapy in English and Spanish. He specializes in cognitive behavioral therapy (CBT) for obsessive-compulsive disorder (OCD) and anxiety disorders, with additional expertise in working with high-performance athletes.
Dr. Valle brings a distinctive international clinical background to his practice. He completed his postdoctoral fellowship at Stanford University School of Medicine’s Department of Psychiatry and Behavioral Sciences and earned his doctorate in clinical psychology from The Wright Institute in Berkeley. He also holds a Master’s degree in crisis and trauma from Tel Aviv University and is a licensed clinical psychologist in Mexico City, his place of origin. -
Peter Johannes van Roessel
Clinical Professor, Psychiatry and Behavioral Sciences
BioDr. Peter van Roessel, MD, PhD, completed his MD at Stanford University and his residency training in psychiatry at Columbia University and the New York-Presbyterian Hospital in New York City, with additional training in psychodynamic psychotherapy via the Columbia University Center for Psychoanalytic Training and Research. Prior to joining the clinical faculty at Stanford, he worked for several years as Associate Director of the general research unit of the New York State Psychiatric Institute, a premier state-funded research hospital affiliated with Columbia University.
At Stanford, Dr. van Roessel sees adult mood and anxiety disorders outpatients through the Assessment and Psychodynamic Psychotherapy Clinics and participates in resident training and patient care as director of the resident Continuity Clinic and as a supervisor in psychodynamic psychotherapy. He additionally directs the third-year resident curriculum in psychopathology and psychopharmacology and co-leads a new adult outpatient ketamine-assisted psychotherapy clinic.
As Director of Clinical Research for the department's Rodriguez Translational Therapeutics Lab, he sees individuals with obsessive-compulsive spectrum disorders for evaluations and research-protocol driven clinical treatment and leads clinical neuroscience studies pioneering rapid-acting interventions in OCD. Clinically motivated research interests include the nature and neural correlates of metacognitive awareness ('insight') in OCD and related disorders, and particularly the relationship of awareness to mechanisms of attentional control and the processing of incongruity and error. Dr. van Roessel additionally contributes as co-investigator to the Suppes Exploratory Therapeutics Laboratory and to the Williams PANLab, on clinical trials advancing psychedelic-assisted psychotherapies and biomarker-informed precision medicine in depression and posttraumatic stress disorder.
Dr. van Roessel pursued research training in basic neuroscience prior to his clinical training, completing an MPhil in Biology via the Open University, UK, for research performed at the Max Planck Institute for Developmental Biology in Tübingen Germany, and a PhD in molecular and developmental neurobiology at the University of Cambridge, UK. He has contributed to work in the lab of Dr Julia Kaltschmidt (Stanford) on studies of GABAergic/Glutamatergic interneuronal circuity in mouse. He received a 2018 NARSAD Young Investigator Award to pursue study of nitrous oxide as a rapid-acting treatment for OCD, he was a 2020-2022 Miller Foundation Fellow, and from 2020 to 2022 was a Advanced Fellow in Mental Illness Treatment and Research via the Sierra Pacific Mental Illness Research, Education, and Clinical Center of the Palo Alto VA. Dr. van Roessel is a Fellow of the American Psychiatric Association and a member of the American College of Psychiatrists. -
Mytilee Vemuri
Clinical Associate Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsI am a Clinical Assistant Professor of Psychiatry, with clinical and research interests in hormonal influences on women’s mental and cognitive health. After Psychiatry residency I completed a NIMH research fellowship studying gender differences in metabolic complications such as dyslipidemia, obesity, and insulin-resistance in patients with bipolar disorder. As a research fellow, I also provided clinical oversight for research participants in studies evaluating hormonal change, metabolic biomarkers and mood. More recently, I have collaborated with PI Duncan and her research group on projects studying relationships between sex hormones and mood/anxiety disorders, particularly in peri-menopausal women. From these experiences I have gained experience in conducting clinical research and collaborating in interdisciplinary research teams. I have also had over 20 years of clinical experience as an attending psychiatrist in Stanford Women’s Wellness psychiatry, general psychiatry and primary care clinics treating a wide range of psychiatric conditions including perimenopausal and geriatric mood disorders. I have published review articles detailing the evidence-basis for treating mood disorders in women during times of hormonal change, and the role of hormones as potential treatments. I also serve as the Stanford Psychiatry Department’s clinical quality improvement leader, where I oversee multiple interdisciplinary improvement teams charged with improving the quality and efficiency of care processes. I currently specialize in managing perimenopausal mood disorders and have an interest in the judicious use of menopausal hormone therapy as an adjunctive treatment for mood symptoms in this population. My clinical and research experience in the intersection of women’s mental health, sex-steroid hormones, and the perimenopause, along with broad experience working on cross-disciplinary teams, will bring valuable input to this research team.
-
Lynn C. Waelde, Ph.D.
Adjunct Clinical Professor, Psychiatry and Behavioral Sciences
BioLynn C. Waelde, Ph.D. is an Adjunct Clinical Professor in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine and Professor Emeritus in the Psychology Department at Palo Alto University. Dr. Waelde’s many collaborative publications address the impacts of traumatic events and ways to use mindfulness and meditation to promote resilience and recovery from stress and trauma. She founded and directed the Inner Resources Center which offered intervention groups and trainings to thousands of participants, clients, and therapists over the past 15 years. Dr. Waelde is the author of Mindfulness and Meditation in Trauma Treatment: The Inner Resources for Stress Program, published in 2022. She has taken a special interest in family caregivers and the Inner Resources for Stress program has been named a Best Practice by the Benjamin Rose Institute on Aging. She recently coauthored Family Caregiver Distress, which is forthcoming in 2023. She is on the editorial board of Journal of Traumatic Stress and an Associate Editor of Mindfulness.
-
Diane Elizabeth Wakeham
Clinical Research Coordinator Associate, Psych/General Psychiatry and Psychology (Adult)
Current Role at StanfordClinical Research Coordinator Associate, INSPIRE Clinic, Psychiatry and Behavioral Sciences
-
Po Wang
Clinical Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsBipolar Disorders, Psychopharmacology, Treatment, Anticonvulsants, Mood stabilizers
-
Kathleen Watson
Instructor, Psychiatry and Behavioral Sciences
BioKathleen Watson, Ph.D., currently serves as an instructor at Stanford University School of Medicine, specializing in Epidemiology and Clinical Research. She co-founded Microclinic International in 2007, where she served as Chief Operating Officer until 2012, focusing on socially-based health interventions for underserved communities.
Dr. Watson's research encompasses various aspects of mental health and metabolism. She investigates the connection between insulin resistance and depression, using computational psychiatry to uncover insights into the interplay of metabolic factors in mental well-being. Additionally, her exploration of cognitive aging examines how metabolic alterations might impact cognitive decline and related disorders. Furthermore, her research in proteomics aims to identify potential biomarkers for severe major depressive disorder. Dr. Watson has recently become a part of the Stanford Autism Center for Excellence Data Core, where she works under the guidance of Dr. Booil Jo.
